Soligenix Reports Second Quarter 2013 Results

barbara.lempert Soligenix Reports Second Quarter 2013 Financial Results, and Highlights Recent Accomplishments    Current Cash Resources Total $ 8.1 Million   Princeton, NJ ...

Aeterna Zentaris Reports Second Quarter 2013 Financial and Operating Results

barbara.lempert All amounts are in U.S. dollars (unless otherwise noted) QUEBEC CITY, Aug. 8, 2013 /CNW Telbec/ – Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”), ...

Malaria vaccine shows early ‘unprecedented’ results in NIH-backed study

Ryan McBride A new kind of malaria vaccine impressed researchers in an early clinical study, providing hope that protection against the lethal parasite could become widely available ...

AMRI Announces Second Quarter 2013 Results

barbara.lempert Second Quarter Revenue up 19% at $ 59.3 Million and Adjusted EPS up 100% to $ 0.12 Albany, NY (August 6, 2013) – AMRI (NASDAQ: AMRI) today reported financial and ...

BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia

barbara.lempert – Results published in the British Journal of Hematology – – BL-8040, currently in Phase 2 study for AML, continues to show promising results in ...

QLT Announces Second Quarter 2013 Results

barbara.lempert VANCOUVER, British Columbia, Aug. 1, 2013 (GLOBE NEWSWIRE) — QLT Inc. (Nasdaq:QLTI) (TSX:QLT) (“QLT” or the “Company”) is a biotechnology ...

HBIO Reports Second Quarter 2013 Results

barbara.lempert HOLLISTON, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools ...

Vical Reports Second Quarter 2013 Financial Results

barbara.lempert Vical Reports Second Quarter 2013 Financial Results, Projects Phase 3 Data Release in August and Establishes Quiet Period SAN DIEGO, Aug. 1, 2013 (GLOBE NEWSWIRE) ...

EpiCept Reports Second Quarter 2013 Operating and Financial Results

barbara.lempert Special August 6 Stockholder Meeting to Approve Final Conditions to Merger with Immune Pharmaceuticals TARRYTOWN, N.Y., Aug. 1, 2013 /PRNewswire/ — EpiCept Corporation ...

Nuvo Research announces 2013 second quarter results

barbara.lempert MISSISSAUGA, ON, July 31, 2013 /CNW/ – Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the ...

Teva Reports Second Quarter 2013 Results

mia.burns Net Revenues of $ 4.9 Billion Non-GAAP Diluted EPS of $ 1.20, GAAP Diluted EPS Loss of $ 0.53 JERUSALEM–(BUSINESS WIRE)–Aug. 1, 2013– Teva Pharmaceutical ...

Cigna Reports Strong Second Quarter 2013 Results, Raises Outlook

barbara.lempert •    Consolidated revenues increased 8% to $ 8.0 billion in the second quarter. •    Adjusted income from operations1 was $ 512 million, or $ 1.78 per ...
Page 3 of 712345...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS